2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Rela
|
ENSMUSG00000024927.7 | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
Rel
|
ENSMUSG00000020275.8 | reticuloendotheliosis oncogene |
Nfkb1
|
ENSMUSG00000028163.11 | nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Rela | mm10_v2_chr19_+_5637475_5637486 | -0.72 | 8.8e-03 | Click! |
Rel | mm10_v2_chr11_-_23770953_23771028 | -0.54 | 6.9e-02 | Click! |
Nfkb1 | mm10_v2_chr3_-_135691512_135691564 | -0.40 | 2.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_165234689 | 3.73 |
ENSMUST00000065438.6
|
Cdh22
|
cadherin 22 |
chr1_+_193301953 | 3.61 |
ENSMUST00000016315.9
|
Lamb3
|
laminin, beta 3 |
chr4_+_150927918 | 3.44 |
ENSMUST00000139826.1
ENSMUST00000116257.1 |
Tnfrsf9
|
tumor necrosis factor receptor superfamily, member 9 |
chr10_+_79664553 | 3.23 |
ENSMUST00000020554.6
|
Madcam1
|
mucosal vascular addressin cell adhesion molecule 1 |
chr7_+_99535439 | 2.85 |
ENSMUST00000098266.2
ENSMUST00000179755.1 |
Arrb1
|
arrestin, beta 1 |
chr9_-_7873157 | 2.51 |
ENSMUST00000159323.1
ENSMUST00000115673.2 |
Birc3
|
baculoviral IAP repeat-containing 3 |
chr4_+_100776664 | 2.40 |
ENSMUST00000030257.8
ENSMUST00000097955.2 |
Cachd1
|
cache domain containing 1 |
chr12_+_79130777 | 2.34 |
ENSMUST00000021550.6
|
Arg2
|
arginase type II |
chr7_+_28766747 | 2.33 |
ENSMUST00000170068.1
ENSMUST00000072965.4 |
Sirt2
|
sirtuin 2 |
chr19_+_6341121 | 2.26 |
ENSMUST00000025897.6
ENSMUST00000130382.1 |
Map4k2
|
mitogen-activated protein kinase kinase kinase kinase 2 |
chr4_-_42168603 | 2.22 |
ENSMUST00000098121.3
|
Gm13305
|
predicted gene 13305 |
chr7_+_99535652 | 2.16 |
ENSMUST00000032995.8
ENSMUST00000162404.1 |
Arrb1
|
arrestin, beta 1 |
chr13_+_112464070 | 2.16 |
ENSMUST00000183663.1
ENSMUST00000184311.1 ENSMUST00000183886.1 |
Il6st
|
interleukin 6 signal transducer |
chr2_-_5063996 | 2.12 |
ENSMUST00000114996.1
|
Optn
|
optineurin |
chr9_-_7873016 | 2.10 |
ENSMUST00000013949.8
|
Birc3
|
baculoviral IAP repeat-containing 3 |
chr19_-_58454580 | 2.08 |
ENSMUST00000129100.1
ENSMUST00000123957.1 |
Gfra1
|
glial cell line derived neurotrophic factor family receptor alpha 1 |
chr15_-_31367527 | 1.96 |
ENSMUST00000076942.4
ENSMUST00000123325.1 ENSMUST00000110410.2 |
Ankrd33b
|
ankyrin repeat domain 33B |
chr15_-_79164477 | 1.94 |
ENSMUST00000040019.4
|
Sox10
|
SRY-box containing gene 10 |
chr11_+_100860447 | 1.92 |
ENSMUST00000107357.2
|
Stat5a
|
signal transducer and activator of transcription 5A |
chr2_-_5063932 | 1.88 |
ENSMUST00000027986.4
|
Optn
|
optineurin |
chr17_+_37193889 | 1.88 |
ENSMUST00000038844.6
|
Ubd
|
ubiquitin D |
chr11_-_106159902 | 1.80 |
ENSMUST00000064545.4
|
Limd2
|
LIM domain containing 2 |
chr11_-_109298121 | 1.78 |
ENSMUST00000020920.3
|
Rgs9
|
regulator of G-protein signaling 9 |
chr12_-_55492587 | 1.77 |
ENSMUST00000021413.7
|
Nfkbia
|
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
chr2_+_144556229 | 1.76 |
ENSMUST00000143573.1
ENSMUST00000028916.8 ENSMUST00000155258.1 |
Sec23b
|
SEC23B (S. cerevisiae) |
chr19_+_46304709 | 1.74 |
ENSMUST00000073116.5
|
Nfkb2
|
nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100 |
chr11_+_93098404 | 1.72 |
ENSMUST00000107859.1
ENSMUST00000042943.6 ENSMUST00000107861.1 ENSMUST00000107858.2 |
Car10
|
carbonic anhydrase 10 |
chr14_-_30607808 | 1.68 |
ENSMUST00000112207.1
ENSMUST00000112206.1 ENSMUST00000112202.1 ENSMUST00000112203.1 |
Prkcd
|
protein kinase C, delta |
chr9_+_22188137 | 1.66 |
ENSMUST00000178901.1
|
Zfp872
|
zinc finger protein 872 |
chr2_-_103303179 | 1.65 |
ENSMUST00000090475.3
|
Ehf
|
ets homologous factor |
chr17_+_33919332 | 1.64 |
ENSMUST00000025161.7
|
Tapbp
|
TAP binding protein |
chr11_-_109298066 | 1.64 |
ENSMUST00000106706.1
|
Rgs9
|
regulator of G-protein signaling 9 |
chr2_+_144556306 | 1.63 |
ENSMUST00000155876.1
ENSMUST00000149697.1 |
Sec23b
|
SEC23B (S. cerevisiae) |
chr18_+_37484955 | 1.63 |
ENSMUST00000053856.4
|
Pcdhb17
|
protocadherin beta 17 |
chr7_-_19629355 | 1.62 |
ENSMUST00000049912.8
ENSMUST00000094762.3 ENSMUST00000098754.4 |
Relb
|
avian reticuloendotheliosis viral (v-rel) oncogene related B |
chr4_+_115088708 | 1.61 |
ENSMUST00000171877.1
ENSMUST00000177647.1 ENSMUST00000106548.2 ENSMUST00000030488.2 |
Pdzk1ip1
|
PDZK1 interacting protein 1 |
chr17_+_55952623 | 1.60 |
ENSMUST00000003274.6
|
Ebi3
|
Epstein-Barr virus induced gene 3 |
chrX_+_164438039 | 1.59 |
ENSMUST00000033755.5
|
Asb11
|
ankyrin repeat and SOCS box-containing 11 |
chr19_-_58454435 | 1.59 |
ENSMUST00000169850.1
|
Gfra1
|
glial cell line derived neurotrophic factor family receptor alpha 1 |
chr10_-_7681118 | 1.57 |
ENSMUST00000159977.1
ENSMUST00000162682.1 |
Pcmt1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase 1 |
chr17_+_35979851 | 1.55 |
ENSMUST00000087200.3
|
Gnl1
|
guanine nucleotide binding protein-like 1 |
chr8_+_71676233 | 1.53 |
ENSMUST00000110013.3
ENSMUST00000051995.7 |
Jak3
|
Janus kinase 3 |
chr11_-_54956047 | 1.52 |
ENSMUST00000155316.1
ENSMUST00000108889.3 ENSMUST00000126703.1 |
Tnip1
|
TNFAIP3 interacting protein 1 |
chr18_+_60803838 | 1.50 |
ENSMUST00000050487.8
ENSMUST00000097563.2 ENSMUST00000167610.1 |
Cd74
|
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
chr19_-_58455161 | 1.49 |
ENSMUST00000135730.1
ENSMUST00000152507.1 |
Gfra1
|
glial cell line derived neurotrophic factor family receptor alpha 1 |
chr10_-_19015347 | 1.49 |
ENSMUST00000019997.4
|
Tnfaip3
|
tumor necrosis factor, alpha-induced protein 3 |
chr2_-_103303158 | 1.49 |
ENSMUST00000111176.2
|
Ehf
|
ets homologous factor |
chr5_-_92348871 | 1.43 |
ENSMUST00000038816.6
ENSMUST00000118006.1 |
Cxcl10
|
chemokine (C-X-C motif) ligand 10 |
chr1_+_150100093 | 1.36 |
ENSMUST00000035065.7
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2 |
chr17_-_34862473 | 1.35 |
ENSMUST00000025229.4
ENSMUST00000176203.2 ENSMUST00000128767.1 |
Cfb
|
complement factor B |
chr17_-_34287770 | 1.33 |
ENSMUST00000174751.1
ENSMUST00000040655.6 |
H2-Aa
|
histocompatibility 2, class II antigen A, alpha |
chr6_-_5256226 | 1.32 |
ENSMUST00000125686.1
ENSMUST00000031773.2 |
Pon3
|
paraoxonase 3 |
chr9_-_7872983 | 1.31 |
ENSMUST00000115672.1
|
Birc3
|
baculoviral IAP repeat-containing 3 |
chr17_+_35194502 | 1.31 |
ENSMUST00000173600.1
|
Ltb
|
lymphotoxin B |
chr1_+_134193432 | 1.31 |
ENSMUST00000038445.6
|
Mybph
|
myosin binding protein H |
chr11_+_101176041 | 1.31 |
ENSMUST00000103109.3
|
Cntnap1
|
contactin associated protein-like 1 |
chr11_-_83530505 | 1.30 |
ENSMUST00000035938.2
|
Ccl5
|
chemokine (C-C motif) ligand 5 |
chr5_+_66968416 | 1.30 |
ENSMUST00000038188.7
|
Limch1
|
LIM and calponin homology domains 1 |
chr11_+_87664274 | 1.29 |
ENSMUST00000092800.5
|
Rnf43
|
ring finger protein 43 |
chr2_+_143546144 | 1.26 |
ENSMUST00000028905.9
|
Pcsk2
|
proprotein convertase subtilisin/kexin type 2 |
chr9_-_14614949 | 1.25 |
ENSMUST00000013220.6
ENSMUST00000160770.1 |
Amotl1
|
angiomotin-like 1 |
chr3_-_83841767 | 1.25 |
ENSMUST00000029623.9
|
Tlr2
|
toll-like receptor 2 |
chr12_+_85686648 | 1.25 |
ENSMUST00000040536.5
|
Batf
|
basic leucine zipper transcription factor, ATF-like |
chr5_-_92328068 | 1.18 |
ENSMUST00000113093.3
|
Cxcl9
|
chemokine (C-X-C motif) ligand 9 |
chr1_-_135258449 | 1.18 |
ENSMUST00000003135.7
|
Elf3
|
E74-like factor 3 |
chr5_+_90891234 | 1.17 |
ENSMUST00000031327.8
|
Cxcl1
|
chemokine (C-X-C motif) ligand 1 |
chr11_-_82179808 | 1.17 |
ENSMUST00000108189.2
ENSMUST00000021043.4 |
Ccl1
|
chemokine (C-C motif) ligand 1 |
chr10_-_127751707 | 1.15 |
ENSMUST00000079692.5
|
Gpr182
|
G protein-coupled receptor 182 |
chr11_-_83578496 | 1.13 |
ENSMUST00000019266.5
|
Ccl9
|
chemokine (C-C motif) ligand 9 |
chr7_-_44815658 | 1.12 |
ENSMUST00000107893.1
|
Atf5
|
activating transcription factor 5 |
chr3_+_28263205 | 1.11 |
ENSMUST00000159236.2
|
Tnik
|
TRAF2 and NCK interacting kinase |
chr11_+_53519725 | 1.09 |
ENSMUST00000108987.1
ENSMUST00000121334.1 ENSMUST00000117061.1 |
Sept8
|
septin 8 |
chr17_+_26933070 | 1.08 |
ENSMUST00000073724.5
|
Phf1
|
PHD finger protein 1 |
chr6_+_48841633 | 1.08 |
ENSMUST00000168406.1
|
Tmem176a
|
transmembrane protein 176A |
chr17_-_35979679 | 1.07 |
ENSMUST00000173724.1
ENSMUST00000172900.1 ENSMUST00000174849.1 |
Prr3
|
proline-rich polypeptide 3 |
chr11_+_100859492 | 1.06 |
ENSMUST00000107356.1
|
Stat5a
|
signal transducer and activator of transcription 5A |
chr17_+_24878724 | 1.05 |
ENSMUST00000050714.6
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit |
chrX_+_7657260 | 1.05 |
ENSMUST00000033485.7
|
Prickle3
|
prickle homolog 3 (Drosophila) |
chr5_+_43818893 | 1.04 |
ENSMUST00000101237.4
|
Bst1
|
bone marrow stromal cell antigen 1 |
chr8_+_84415348 | 1.03 |
ENSMUST00000121390.1
ENSMUST00000122053.1 |
Cacna1a
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
chr10_-_75797528 | 1.03 |
ENSMUST00000120177.1
|
Gstt1
|
glutathione S-transferase, theta 1 |
chr3_-_102936093 | 1.02 |
ENSMUST00000029448.6
|
Sycp1
|
synaptonemal complex protein 1 |
chr11_+_114727384 | 1.02 |
ENSMUST00000069325.7
|
Dnaic2
|
dynein, axonemal, intermediate chain 2 |
chr2_-_157566319 | 1.02 |
ENSMUST00000109528.2
ENSMUST00000088494.2 |
Blcap
|
bladder cancer associated protein homolog (human) |
chr12_+_109747903 | 1.01 |
ENSMUST00000183084.1
ENSMUST00000182300.1 |
Mirg
|
miRNA containing gene |
chr18_-_4352944 | 1.01 |
ENSMUST00000025078.2
|
Map3k8
|
mitogen-activated protein kinase kinase kinase 8 |
chr11_-_109298090 | 1.00 |
ENSMUST00000106704.2
|
Rgs9
|
regulator of G-protein signaling 9 |
chr8_-_25101985 | 1.00 |
ENSMUST00000128715.1
ENSMUST00000064883.6 |
Plekha2
|
pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 2 |
chr11_+_53519920 | 1.00 |
ENSMUST00000147912.1
|
Sept8
|
septin 8 |
chr12_+_111442453 | 0.95 |
ENSMUST00000102745.3
|
Tnfaip2
|
tumor necrosis factor, alpha-induced protein 2 |
chrX_-_102908672 | 0.93 |
ENSMUST00000119624.1
ENSMUST00000033686.1 |
Dmrtc1a
|
DMRT-like family C1a |
chr4_-_125127817 | 0.92 |
ENSMUST00000036188.7
|
Zc3h12a
|
zinc finger CCCH type containing 12A |
chr17_+_45555693 | 0.91 |
ENSMUST00000024742.7
|
Nfkbie
|
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, epsilon |
chr10_+_127048235 | 0.90 |
ENSMUST00000165764.1
|
Cyp27b1
|
cytochrome P450, family 27, subfamily b, polypeptide 1 |
chr6_+_48841476 | 0.89 |
ENSMUST00000101426.4
|
Tmem176a
|
transmembrane protein 176A |
chr11_+_90030295 | 0.88 |
ENSMUST00000092788.3
|
Tmem100
|
transmembrane protein 100 |
chr7_-_127014585 | 0.88 |
ENSMUST00000165096.2
|
Mvp
|
major vault protein |
chr11_+_87664549 | 0.87 |
ENSMUST00000121782.2
|
Rnf43
|
ring finger protein 43 |
chr3_+_142496924 | 0.87 |
ENSMUST00000090127.2
|
Gbp5
|
guanylate binding protein 5 |
chr11_+_53519871 | 0.87 |
ENSMUST00000120878.2
|
Sept8
|
septin 8 |
chr5_+_136967859 | 0.87 |
ENSMUST00000001790.5
|
Cldn15
|
claudin 15 |
chr7_+_75455534 | 0.87 |
ENSMUST00000147005.1
ENSMUST00000166315.1 |
Akap13
|
A kinase (PRKA) anchor protein 13 |
chr13_+_18948344 | 0.85 |
ENSMUST00000003345.7
|
Amph
|
amphiphysin |
chr11_-_69880971 | 0.85 |
ENSMUST00000050555.3
|
Kctd11
|
potassium channel tetramerisation domain containing 11 |
chr17_+_35821675 | 0.84 |
ENSMUST00000003635.6
|
Ier3
|
immediate early response 3 |
chr10_+_81574699 | 0.84 |
ENSMUST00000131794.1
ENSMUST00000136341.1 |
Tle2
|
transducin-like enhancer of split 2, homolog of Drosophila E(spl) |
chr8_-_84042540 | 0.84 |
ENSMUST00000005601.7
|
Il27ra
|
interleukin 27 receptor, alpha |
chr10_-_81627797 | 0.84 |
ENSMUST00000042923.8
|
Sirt6
|
sirtuin 6 |
chr17_-_35979237 | 0.83 |
ENSMUST00000165613.2
ENSMUST00000173872.1 |
Prr3
|
proline-rich polypeptide 3 |
chr18_+_37742088 | 0.83 |
ENSMUST00000003599.6
|
Pcdhga9
|
protocadherin gamma subfamily A, 9 |
chr12_-_80132802 | 0.81 |
ENSMUST00000180643.1
|
2310015A10Rik
|
RIKEN cDNA 2310015A10 gene |
chr6_-_129275360 | 0.81 |
ENSMUST00000032259.3
|
Cd69
|
CD69 antigen |
chr16_+_93683184 | 0.81 |
ENSMUST00000039620.6
|
Cbr3
|
carbonyl reductase 3 |
chr13_+_33964659 | 0.80 |
ENSMUST00000021843.5
ENSMUST00000058978.7 |
Nqo2
|
NAD(P)H dehydrogenase, quinone 2 |
chr8_-_25101734 | 0.79 |
ENSMUST00000098866.4
|
Plekha2
|
pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 2 |
chr14_-_30626196 | 0.78 |
ENSMUST00000112210.3
ENSMUST00000112211.2 ENSMUST00000112208.1 |
Prkcd
|
protein kinase C, delta |
chr10_+_80930071 | 0.78 |
ENSMUST00000015456.8
|
Gadd45b
|
growth arrest and DNA-damage-inducible 45 beta |
chr1_-_173333503 | 0.78 |
ENSMUST00000038227.4
|
Darc
|
Duffy blood group, chemokine receptor |
chr2_-_152830615 | 0.77 |
ENSMUST00000146380.1
ENSMUST00000134902.1 ENSMUST00000134357.1 ENSMUST00000109820.3 |
Bcl2l1
|
BCL2-like 1 |
chr6_-_131313827 | 0.77 |
ENSMUST00000049150.1
|
Styk1
|
serine/threonine/tyrosine kinase 1 |
chr4_-_40239700 | 0.77 |
ENSMUST00000142055.1
|
Ddx58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr2_-_164443177 | 0.77 |
ENSMUST00000017153.3
|
Sdc4
|
syndecan 4 |
chr18_+_37477768 | 0.76 |
ENSMUST00000051442.5
|
Pcdhb16
|
protocadherin beta 16 |
chr11_+_82115180 | 0.74 |
ENSMUST00000009329.2
|
Ccl8
|
chemokine (C-C motif) ligand 8 |
chr7_+_12977834 | 0.74 |
ENSMUST00000108537.1
ENSMUST00000108535.1 ENSMUST00000045810.7 |
Zfp446
|
zinc finger protein 446 |
chr19_+_53529100 | 0.73 |
ENSMUST00000038287.6
|
Dusp5
|
dual specificity phosphatase 5 |
chr10_-_81627257 | 0.73 |
ENSMUST00000143424.1
ENSMUST00000119324.1 |
Sirt6
|
sirtuin 6 |
chr4_+_136286061 | 0.73 |
ENSMUST00000069195.4
ENSMUST00000130658.1 |
Zfp46
|
zinc finger protein 46 |
chr11_+_70647258 | 0.73 |
ENSMUST00000037534.7
|
Rnf167
|
ring finger protein 167 |
chr1_-_182282218 | 0.73 |
ENSMUST00000133052.1
|
Degs1
|
degenerative spermatocyte homolog 1 (Drosophila) |
chr8_-_122432924 | 0.72 |
ENSMUST00000017604.8
|
Cyba
|
cytochrome b-245, alpha polypeptide |
chr11_+_85353156 | 0.71 |
ENSMUST00000108061.1
ENSMUST00000108062.1 ENSMUST00000108056.1 ENSMUST00000138423.1 ENSMUST00000074875.4 ENSMUST00000092821.3 |
Bcas3
|
breast carcinoma amplified sequence 3 |
chr9_+_46998931 | 0.71 |
ENSMUST00000178065.1
|
Gm4791
|
predicted gene 4791 |
chr2_+_120567652 | 0.70 |
ENSMUST00000110711.2
|
Snap23
|
synaptosomal-associated protein 23 |
chr11_-_101175440 | 0.70 |
ENSMUST00000062759.3
|
Ccr10
|
chemokine (C-C motif) receptor 10 |
chr5_+_64970069 | 0.70 |
ENSMUST00000031080.8
|
Fam114a1
|
family with sequence similarity 114, member A1 |
chr7_+_29134854 | 0.70 |
ENSMUST00000161522.1
ENSMUST00000159975.1 ENSMUST00000032811.5 ENSMUST00000094617.4 |
Rasgrp4
|
RAS guanyl releasing protein 4 |
chr4_-_45012093 | 0.69 |
ENSMUST00000131991.1
|
Zbtb5
|
zinc finger and BTB domain containing 5 |
chr18_+_36560581 | 0.69 |
ENSMUST00000155329.2
|
Ankhd1
|
ankyrin repeat and KH domain containing 1 |
chr12_+_111442653 | 0.69 |
ENSMUST00000109792.1
|
Tnfaip2
|
tumor necrosis factor, alpha-induced protein 2 |
chr9_+_75410145 | 0.68 |
ENSMUST00000180533.1
ENSMUST00000180574.1 |
4933433G15Rik
|
RIKEN cDNA 4933433G15 gene |
chr2_+_164948219 | 0.68 |
ENSMUST00000017881.2
|
Mmp9
|
matrix metallopeptidase 9 |
chr12_+_79029150 | 0.67 |
ENSMUST00000039928.5
|
Plekhh1
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 |
chr8_-_88636117 | 0.67 |
ENSMUST00000034087.7
|
Snx20
|
sorting nexin 20 |
chr9_-_58159201 | 0.66 |
ENSMUST00000041477.7
|
Islr
|
immunoglobulin superfamily containing leucine-rich repeat |
chr5_+_90903864 | 0.66 |
ENSMUST00000075433.6
|
Cxcl2
|
chemokine (C-X-C motif) ligand 2 |
chr3_-_113258837 | 0.65 |
ENSMUST00000098673.3
|
Amy2a5
|
amylase 2a5 |
chr15_-_75747922 | 0.65 |
ENSMUST00000062002.4
|
Mafa
|
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (avian) |
chr3_-_101836223 | 0.65 |
ENSMUST00000061831.4
|
Mab21l3
|
mab-21-like 3 (C. elegans) |
chr2_+_120567687 | 0.65 |
ENSMUST00000028743.3
ENSMUST00000116437.1 ENSMUST00000153580.1 ENSMUST00000142278.1 |
Snap23
|
synaptosomal-associated protein 23 |
chr14_+_65970610 | 0.65 |
ENSMUST00000127387.1
|
Clu
|
clusterin |
chr7_-_31110997 | 0.65 |
ENSMUST00000039435.8
|
Hpn
|
hepsin |
chr17_-_24205514 | 0.65 |
ENSMUST00000097376.3
ENSMUST00000168410.2 ENSMUST00000167791.2 ENSMUST00000040474.7 |
Tbc1d24
|
TBC1 domain family, member 24 |
chr19_-_5845471 | 0.64 |
ENSMUST00000174287.1
ENSMUST00000173672.1 |
Neat1
|
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
chr10_-_41709297 | 0.64 |
ENSMUST00000019955.9
ENSMUST00000099932.3 |
Ccdc162
|
coiled-coil domain containing 162 |
chr4_+_130915949 | 0.64 |
ENSMUST00000030316.6
|
Laptm5
|
lysosomal-associated protein transmembrane 5 |
chr11_-_54962903 | 0.64 |
ENSMUST00000108885.1
ENSMUST00000102730.2 ENSMUST00000018482.6 ENSMUST00000108886.1 ENSMUST00000102731.1 |
Tnip1
|
TNFAIP3 interacting protein 1 |
chr18_+_37736897 | 0.64 |
ENSMUST00000091935.4
|
Pcdhga9
|
protocadherin gamma subfamily A, 9 |
chr7_-_27396542 | 0.64 |
ENSMUST00000108363.1
|
Sptbn4
|
spectrin beta, non-erythrocytic 4 |
chr18_-_20059478 | 0.64 |
ENSMUST00000075214.2
ENSMUST00000039247.4 |
Dsc2
|
desmocollin 2 |
chr3_-_67463828 | 0.64 |
ENSMUST00000058981.2
|
Lxn
|
latexin |
chr2_-_143862933 | 0.63 |
ENSMUST00000099296.3
|
Bfsp1
|
beaded filament structural protein 1, in lens-CP94 |
chr4_-_40722307 | 0.63 |
ENSMUST00000181475.1
|
Gm6297
|
predicted gene 6297 |
chr6_-_48841098 | 0.63 |
ENSMUST00000101429.4
|
Tmem176b
|
transmembrane protein 176B |
chr2_+_25395866 | 0.63 |
ENSMUST00000028328.2
|
Entpd2
|
ectonucleoside triphosphate diphosphohydrolase 2 |
chr4_-_40239779 | 0.63 |
ENSMUST00000037907.6
|
Ddx58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr16_-_33056174 | 0.63 |
ENSMUST00000115100.1
ENSMUST00000040309.8 |
Iqcg
|
IQ motif containing G |
chr14_+_80000292 | 0.63 |
ENSMUST00000088735.3
|
Olfm4
|
olfactomedin 4 |
chr12_+_52699297 | 0.62 |
ENSMUST00000095737.3
|
Akap6
|
A kinase (PRKA) anchor protein 6 |
chr15_-_5063741 | 0.62 |
ENSMUST00000110689.3
|
C7
|
complement component 7 |
chr7_-_30861470 | 0.62 |
ENSMUST00000052700.3
|
Ffar1
|
free fatty acid receptor 1 |
chr8_+_114133557 | 0.61 |
ENSMUST00000073521.5
ENSMUST00000066514.6 |
Nudt7
|
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
chr8_+_114133601 | 0.61 |
ENSMUST00000109109.1
|
Nudt7
|
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
chr10_+_80702649 | 0.61 |
ENSMUST00000095426.3
|
Izumo4
|
IZUMO family member 4 |
chr3_+_89421619 | 0.60 |
ENSMUST00000094378.3
ENSMUST00000137793.1 |
Shc1
|
src homology 2 domain-containing transforming protein C1 |
chr3_+_89229046 | 0.60 |
ENSMUST00000041142.3
|
Muc1
|
mucin 1, transmembrane |
chr5_-_137116177 | 0.59 |
ENSMUST00000054384.5
ENSMUST00000152207.1 |
Trim56
|
tripartite motif-containing 56 |
chr5_+_57718021 | 0.59 |
ENSMUST00000094783.3
ENSMUST00000068110.7 |
Pcdh7
|
protocadherin 7 |
chr4_+_137681663 | 0.59 |
ENSMUST00000047243.5
|
Rap1gap
|
Rap1 GTPase-activating protein |
chr11_+_95009852 | 0.59 |
ENSMUST00000055947.3
|
Samd14
|
sterile alpha motif domain containing 14 |
chr9_-_14615473 | 0.59 |
ENSMUST00000162901.1
|
Amotl1
|
angiomotin-like 1 |
chr13_+_55152640 | 0.58 |
ENSMUST00000005452.5
|
Fgfr4
|
fibroblast growth factor receptor 4 |
chr2_-_84743655 | 0.58 |
ENSMUST00000181711.1
|
Gm19426
|
predicted gene, 19426 |
chr6_-_48840988 | 0.58 |
ENSMUST00000164733.1
|
Tmem176b
|
transmembrane protein 176B |
chr8_-_71676674 | 0.58 |
ENSMUST00000066837.4
|
Gm9933
|
predicted gene 9933 |
chr4_+_102589687 | 0.58 |
ENSMUST00000097949.4
ENSMUST00000106901.1 |
Pde4b
|
phosphodiesterase 4B, cAMP specific |
chr14_-_70642268 | 0.57 |
ENSMUST00000022697.5
|
Fgf17
|
fibroblast growth factor 17 |
chr7_-_57387172 | 0.57 |
ENSMUST00000068911.6
|
Gabrg3
|
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3 |
chr5_-_105293699 | 0.57 |
ENSMUST00000050011.8
|
Gbp6
|
guanylate binding protein 6 |
chr11_-_78697370 | 0.57 |
ENSMUST00000142739.1
|
Nlk
|
nemo like kinase |
chr1_+_130800902 | 0.56 |
ENSMUST00000112477.2
ENSMUST00000027670.3 |
Fcamr
|
Fc receptor, IgA, IgM, high affinity |
chr11_-_115187827 | 0.56 |
ENSMUST00000103041.1
|
Nat9
|
N-acetyltransferase 9 (GCN5-related, putative) |
chr9_+_54698859 | 0.55 |
ENSMUST00000120452.1
|
Dnaja4
|
DnaJ (Hsp40) homolog, subfamily A, member 4 |
chr18_+_51117754 | 0.55 |
ENSMUST00000116639.2
|
Prr16
|
proline rich 16 |
chr8_+_114133635 | 0.55 |
ENSMUST00000147605.1
ENSMUST00000134593.1 |
Nudt7
|
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
chr14_-_70429072 | 0.55 |
ENSMUST00000048129.4
|
Piwil2
|
piwi-like RNA-mediated gene silencing 2 |
chr10_+_86705811 | 0.55 |
ENSMUST00000061458.7
ENSMUST00000075632.6 |
BC030307
|
cDNA sequence BC030307 |
chr8_+_125669818 | 0.54 |
ENSMUST00000053078.3
|
Map10
|
microtubule-associated protein 10 |
chr12_+_64917901 | 0.54 |
ENSMUST00000058135.4
|
Gm527
|
predicted gene 527 |
chr3_-_116423930 | 0.54 |
ENSMUST00000106491.2
|
Cdc14a
|
CDC14 cell division cycle 14A |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 3.4 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.8 | 5.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.8 | 4.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.7 | 2.1 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.7 | 2.6 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.7 | 2.0 | GO:0070104 | negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
0.6 | 2.4 | GO:0060376 | positive regulation of mast cell differentiation(GO:0060376) |
0.6 | 2.3 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.5 | 1.6 | GO:0002631 | regulation of granuloma formation(GO:0002631) negative regulation of granuloma formation(GO:0002632) regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) |
0.5 | 3.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.5 | 1.6 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.5 | 1.5 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.5 | 0.5 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.5 | 2.5 | GO:0060697 | glucosylceramide catabolic process(GO:0006680) positive regulation of phospholipid catabolic process(GO:0060697) |
0.5 | 1.5 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.5 | 1.8 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.4 | 1.8 | GO:0046356 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) acetyl-CoA catabolic process(GO:0046356) |
0.4 | 1.8 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.4 | 1.3 | GO:0046271 | coumarin metabolic process(GO:0009804) phenylpropanoid catabolic process(GO:0046271) |
0.4 | 1.2 | GO:0032741 | cell surface pattern recognition receptor signaling pathway(GO:0002752) positive regulation of interleukin-18 production(GO:0032741) response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) detection of bacterial lipopeptide(GO:0070340) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.4 | 6.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.4 | 1.5 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.4 | 3.0 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.4 | 2.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.4 | 1.4 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.4 | 2.8 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.3 | 1.0 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.3 | 1.0 | GO:0050883 | regulation of sulfur amino acid metabolic process(GO:0031335) musculoskeletal movement, spinal reflex action(GO:0050883) |
0.3 | 1.0 | GO:0042197 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.3 | 1.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.3 | 1.4 | GO:1902219 | maintenance of blood-brain barrier(GO:0035633) positive regulation of fibroblast growth factor production(GO:0090271) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 1.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.3 | 1.9 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 1.3 | GO:0030070 | insulin processing(GO:0030070) |
0.3 | 0.9 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
0.3 | 1.5 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.3 | 1.1 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.3 | 1.4 | GO:0035546 | detection of virus(GO:0009597) interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
0.3 | 0.8 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.7 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.2 | 1.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.2 | 0.9 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.2 | 1.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 4.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 0.6 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.2 | 1.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 4.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.9 | GO:0032329 | serine transport(GO:0032329) |
0.2 | 0.5 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.2 | 0.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.7 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.2 | 0.8 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.2 | 1.4 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.2 | 0.7 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.2 | 0.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 0.5 | GO:0010760 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.5 | GO:0006127 | glycerophosphate shuttle(GO:0006127) glycerol-3-phosphate catabolic process(GO:0046168) |
0.2 | 0.5 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.2 | 1.5 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.2 | 0.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.6 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.1 | 0.9 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.1 | 1.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 1.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.5 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.4 | GO:0015881 | creatine transport(GO:0015881) |
0.1 | 0.3 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.4 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.1 | 0.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 0.5 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.5 | GO:0032382 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
0.1 | 2.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 2.0 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 2.5 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.6 | GO:1990839 | response to endothelin(GO:1990839) |
0.1 | 0.7 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.4 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.1 | 0.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 2.3 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 5.7 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.3 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 1.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 1.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.6 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.1 | 0.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.8 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 0.3 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.1 | 1.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.1 | GO:2000229 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.1 | 0.3 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 0.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 1.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.3 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.7 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.4 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.3 | GO:0010286 | heat acclimation(GO:0010286) |
0.1 | 0.6 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 1.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 1.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.2 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 0.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.2 | GO:1902220 | positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902220) |
0.1 | 0.1 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.6 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 3.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 1.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 0.7 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.2 | GO:0002856 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
0.1 | 0.6 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 1.4 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.2 | GO:0036115 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) fatty-acyl-CoA catabolic process(GO:0036115) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.1 | 0.2 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.1 | 2.8 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.2 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.1 | 0.8 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.3 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 1.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.2 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.1 | 0.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.2 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.1 | 0.3 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.2 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.0 | 0.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.1 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
0.0 | 0.2 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.0 | 0.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.7 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) notochord formation(GO:0014028) |
0.0 | 0.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.4 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) embryonic hindgut morphogenesis(GO:0048619) myoblast fate commitment(GO:0048625) |
0.0 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.0 | 0.5 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.8 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.0 | 0.4 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.7 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.3 | GO:0032264 | IMP salvage(GO:0032264) |
0.0 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.2 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.0 | 0.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.2 | GO:0072362 | regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
0.0 | 0.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.7 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 1.0 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.0 | 3.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.6 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.0 | 0.6 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 1.0 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.0 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.2 | GO:0044805 | late nucleophagy(GO:0044805) |
0.0 | 0.5 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.0 | 0.1 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.0 | 0.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.2 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.0 | 0.1 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.0 | 0.6 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.0 | 0.1 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.0 | 0.2 | GO:0010226 | response to lithium ion(GO:0010226) |
0.0 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.1 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.2 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.1 | GO:0021917 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
0.0 | 0.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.1 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.0 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.1 | GO:1904847 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.1 | GO:1902031 | malate metabolic process(GO:0006108) regulation of NADP metabolic process(GO:1902031) |
0.0 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.1 | GO:1901738 | regulation of isoprenoid metabolic process(GO:0019747) regulation of vitamin A metabolic process(GO:1901738) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 3.2 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation(GO:0050731) |
0.0 | 0.8 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.0 | 3.1 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.2 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.0 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.0 | 0.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.8 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.3 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.0 | 0.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.3 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.5 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.7 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.0 | 0.4 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.0 | 0.0 | GO:0035553 | oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.2 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.0 | 0.4 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.5 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.0 | 0.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.0 | 0.3 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.5 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.6 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.5 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
0.0 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.0 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) negative regulation of cerebellar granule cell precursor proliferation(GO:0021941) |
0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.0 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.0 | 0.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.2 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 0.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 1.3 | GO:0042098 | T cell proliferation(GO:0042098) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 3.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.7 | 2.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.7 | 2.1 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.4 | 2.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 4.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 4.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 1.0 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 2.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 1.9 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 1.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 0.8 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.2 | 2.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 1.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 1.4 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 1.9 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 1.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.7 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 1.4 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.3 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.3 | GO:0043512 | inhibin-betaglycan-ActRII complex(GO:0034673) inhibin A complex(GO:0043512) |
0.1 | 0.6 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 1.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 4.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 1.8 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.8 | GO:0002177 | manchette(GO:0002177) |
0.1 | 1.0 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 1.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.2 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.1 | 0.3 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.6 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 1.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 0.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.5 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.0 | 0.4 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.0 | 0.1 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.0 | 0.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 2.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 1.9 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 1.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.2 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.0 | 0.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 12.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.6 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.4 | GO:0005767 | secondary lysosome(GO:0005767) |
0.0 | 0.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 0.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 1.8 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 8.0 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 2.6 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.4 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.0 | GO:0031251 | PAN complex(GO:0031251) |
0.0 | 0.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 0.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 1.4 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.0 | 0.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 0.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 2.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.0 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.0 | 0.2 | GO:0032156 | septin cytoskeleton(GO:0032156) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.0 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.8 | 3.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.7 | 2.2 | GO:0004923 | interleukin-6 receptor activity(GO:0004915) leukemia inhibitory factor receptor activity(GO:0004923) interleukin-6 binding(GO:0019981) |
0.6 | 2.5 | GO:0070976 | TIR domain binding(GO:0070976) |
0.6 | 2.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) tubulin deacetylase activity(GO:0042903) |
0.5 | 1.6 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.5 | 3.2 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.4 | 4.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.4 | 1.3 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.4 | 1.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.4 | 1.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 1.0 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.3 | 1.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 0.8 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.3 | 1.9 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.3 | 2.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 1.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 2.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 0.8 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.2 | 0.7 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.2 | 1.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 0.7 | GO:0001566 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.2 | 1.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 1.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 2.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.6 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 0.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 0.5 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 1.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 1.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.4 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.1 | 0.5 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.1 | 1.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.5 | GO:0033814 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
0.1 | 3.1 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 3.6 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 5.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.5 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.3 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.1 | 0.4 | GO:0010340 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.1 | 0.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.3 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.8 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 3.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.5 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
0.1 | 0.7 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.3 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 1.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.3 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 0.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.2 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 1.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.2 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.1 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 1.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 1.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.2 | GO:0031694 | alpha2-adrenergic receptor activity(GO:0004938) alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.4 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 1.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 1.0 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.2 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 1.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.0 | 1.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.0 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 1.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.6 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 5.1 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 1.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 1.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.6 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 2.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 2.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 1.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 2.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.5 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.7 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 1.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 4.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.0 | 0.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.3 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 1.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.7 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 1.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.6 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.4 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 1.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 5.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 6.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 2.3 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 6.0 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.0 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.0 | 0.7 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 1.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 12.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 3.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 6.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 4.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 5.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 3.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 5.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 2.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 5.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 2.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 2.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 2.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 1.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 1.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 1.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 1.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.9 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 1.5 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 1.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 1.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 8.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 5.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 3.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 1.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 1.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 6.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 5.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 5.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.7 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 3.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 1.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 2.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 1.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.3 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.8 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 4.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 2.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 1.0 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 1.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 1.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.5 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 1.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.9 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |